Eli Lilly and Company (LLY)

Operating profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	3,024,300	316,700	564,300	-483,600	-138,600
Revenue	US$ in thousands	45,042,700	34,124,100	28,541,400	28,318,400	24,539,800
Operating profit margin		6.71%	0.93%	1.98%	-1.71%	-0.56%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $3,024,300K ÷ $45,042,700K
= 6.71%

Eli Lilly and Company's operating profit margin has shown a mixed performance over the past five years. The margin stood at -0.56% on December 31, 2020, indicating that the company was experiencing a slight loss from its operations. However, this margin worsened in the following year, dropping to -1.71%, reflecting a deeper decline in profitability.

The company managed to turn this negative trend around in December 31, 2022, achieving an operating profit margin of 1.98%, which suggests an improvement in efficiency and effective cost management. This positive momentum was sustained in the subsequent year, with the margin increasing to 0.93%, albeit at a slower pace.

The most significant improvement in Eli Lilly's operating profit margin was witnessed on December 31, 2024, when it reached 6.71%. This substantial increase indicates a considerable boost in profitability, potentially driven by successful strategic initiatives, revenue growth, or cost-saving measures.

Overall, Eli Lilly and Company's operating profit margin trajectory reflects a combination of challenges and successes, with the company exhibiting a notable recovery and strong performance in the later years of the analyzed period.